157 related articles for article (PubMed ID: 7695296)
1. Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases.
Blazquez J; Morosini MI; Negri MC; Gonzalez-Leiza M; Baquero F
Antimicrob Agents Chemother; 1995 Jan; 39(1):145-9. PubMed ID: 7695296
[TBL] [Abstract][Full Text] [Related]
2. Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime.
Cantu C; Huang W; Palzkill T
J Biol Chem; 1996 Sep; 271(37):22538-45. PubMed ID: 8798421
[TBL] [Abstract][Full Text] [Related]
3. A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamases.
Blázquez J; Negri MC; Morosini MI; Gómez-Gómez JM; Baquero F
Antimicrob Agents Chemother; 1998 May; 42(5):1042-4. PubMed ID: 9593123
[TBL] [Abstract][Full Text] [Related]
4. Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type beta-lactamases probed by site-directed mutagenesis and three-dimensional modeling.
Huletsky A; Knox JR; Levesque RC
J Biol Chem; 1993 Feb; 268(5):3690-7. PubMed ID: 8429044
[TBL] [Abstract][Full Text] [Related]
5. Substitution of lysine at position 104 or 240 of TEM-1pTZ18R beta-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam.
Sowek JA; Singer SB; Ohringer S; Malley MF; Dougherty TJ; Gougoutas JZ; Bush K
Biochemistry; 1991 Apr; 30(13):3179-88. PubMed ID: 1901218
[TBL] [Abstract][Full Text] [Related]
6. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.
Petrosino JF; Palzkill T
J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154
[TBL] [Abstract][Full Text] [Related]
7. Characterization of TEM-1 beta-lactamase mutants from positions 238 to 241 with increased catalytic efficiency for ceftazidime.
Venkatachalam KV; Huang W; LaRocco M; Palzkill T
J Biol Chem; 1994 Sep; 269(38):23444-50. PubMed ID: 8089110
[TBL] [Abstract][Full Text] [Related]
8. New mutations in ADC-type β-lactamases from Acinetobacter spp. affect cefoxitin and ceftazidime hydrolysis.
Pérez A; Pérez-Llarena FJ; García P; Kerff F; Beceiro A; Galleni M; Bou G
J Antimicrob Chemother; 2014 Sep; 69(9):2407-11. PubMed ID: 24845871
[TBL] [Abstract][Full Text] [Related]
9. Identification of amino acid substitutions that alter the substrate specificity of TEM-1 beta-lactamase.
Palzkill T; Botstein D
J Bacteriol; 1992 Aug; 174(16):5237-43. PubMed ID: 1644749
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characteristics of extended broad spectrum beta-lactamases.
Bush K; Singer SB
Infection; 1989; 17(6):429-33. PubMed ID: 2613337
[TBL] [Abstract][Full Text] [Related]
11. Substitution of serine for arginine in position 162 of TEM-type beta-lactamases extends the substrate profile of mutant enzymes, TEM-7 and TEM-101, to ceftazidime and aztreonam.
Collatz E; Tran Van Nhieu G; Billot-Klein D; Williamson R; Gutmann L
Gene; 1989 May; 78(2):349-54. PubMed ID: 2506109
[TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.
Stapleton PD; Shannon KP; French GL
Antimicrob Agents Chemother; 1999 Aug; 43(8):1881-7. PubMed ID: 10428907
[TBL] [Abstract][Full Text] [Related]
13. [Meropenem against bacteria carriers of wide spectrum TEM beta-lactamases: evolutive aspects].
Baquero F; Morosini MI; Negri MC; Cantón R; Blázquez J
Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():27-31. PubMed ID: 9410066
[TBL] [Abstract][Full Text] [Related]
14. Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum beta-lactamase TEM-9 (RHH-1) of Klebsiella pneumoniae.
Mabilat C; Goussard S; Sougakoff W; Spencer RC; Courvalin P
Plasmid; 1990 Jan; 23(1):27-34. PubMed ID: 2161546
[TBL] [Abstract][Full Text] [Related]
15. Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.
Chanal-Claris C; Sirot D; Bret L; Chatron P; Labia R; Sirot J
Antimicrob Agents Chemother; 1997 Mar; 41(3):715-6. PubMed ID: 9056022
[TBL] [Abstract][Full Text] [Related]
16. A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate.
Sirot D; Recule C; Chaibi EB; Bret L; Croize J; Chanal-Claris C; Labia R; Sirot J
Antimicrob Agents Chemother; 1997 Jun; 41(6):1322-5. PubMed ID: 9174192
[TBL] [Abstract][Full Text] [Related]
17. Evolution of TEM-type extended-spectrum β-lactamases in Escherichia coli by cephalosporins.
Clasen J; Birkegård AC; Græsbøll K; Folkesson A
J Glob Antimicrob Resist; 2019 Dec; 19():32-39. PubMed ID: 31048029
[TBL] [Abstract][Full Text] [Related]
18. Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60.
Franceschini N; Perilli M; Segatore B; Setacci D; Amicosante G; Mazzariol A; Cornaglia G
Antimicrob Agents Chemother; 1998 Jun; 42(6):1459-62. PubMed ID: 9624494
[TBL] [Abstract][Full Text] [Related]
19. Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
Giakkoupi P; Hujer AM; Miriagou V; Tzelepi E; Bonomo RA; Tzouvelekis LS
FEMS Microbiol Lett; 2001 Jul; 201(1):37-40. PubMed ID: 11445164
[TBL] [Abstract][Full Text] [Related]
20. Role of Asp104 in the SHV beta-lactamase.
Bethel CR; Hujer AM; Hujer KM; Thomson JM; Ruszczycky MW; Anderson VE; Pusztai-Carey M; Taracila M; Helfand MS; Bonomo RA
Antimicrob Agents Chemother; 2006 Dec; 50(12):4124-31. PubMed ID: 16982784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
